Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RECO Flow Restoration Device Versus Solitaire FR With the Intention for Thrombectomy Study: a Prospective Randomised Control Trial(REDIRECT)

NCT01983644 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT01983644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01983644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RECO Flow Restoration Device Versus Solitaire FR With the Intention for Thrombectomy Study: a Prospective Randomised Control Trial(REDIRECT)
Lead sponsor
Jinling Hospital, China
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2013
Completion date
December 31, 2017
Enrollment
130 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke